ªð¦^   ¤À¤l¥Íª«¾Ç½×¾Â > ¤À¤l¬ã¨s¨Æ©y½×¾Â > ³J¥Õ½è¬ì¾Ç > §ÜÅé½×¾Â
±H¦s¾¹ Blogs ±`¨£°ÝÃD¸Ñµª ¦¨­û¦Cªí ¤é¾ä ¬ì¾Ç½s²Õ ·s«Ø! «ý´Y ·j¯Á ¤µ¤Ñ¹L±b ¼Ð°O½×¾ÂŪ

§ÜÅé½×¾Â §ÜÅé½×¾Â¡C­n¨D©M°Q½×§ÜÅé¨ÑÀ³°Ó¡B§ÜÅé¬ÛÃöªº§Þ³N©M¨óij, ©M§ÜÅé¥Í²£Ä´¦p¨Ï¥Î¾½µßªºÅã¥Ü¹Ï®ÑÀ]¡C


Monoclonal §ÜÅ骺¥Í²£- §Þ³N¦b·Æ¹«

§ÜÅé½×¾Â

§ÜÅé½×¾Â¡C­n¨D©M°Q½×§ÜÅé¨ÑÀ³°Ó¡B§ÜÅé¬ÛÃöªº§Þ³N©M¨óij, ©M§ÜÅé¥Í²£Ä´¦p¨Ï¥Î¾½µßªºÅã¥Ü¹Ï®ÑÀ]¡C



µn°O¤À¤l¥Íª«¾Ç½×¾Â
¦^´_
 
LinkBack ½uµ{¼Æ¤u¨ã Åã¥Ü¼Ò¦¡
  #1 (permalink)  
¦Ñ 09-06-2006, ¤U¤È08:00
§l²¾ºÞ¸É¥Õ
ÂI:1,225, ¯Å§O:20ÂI:1,225, ¯Å§O:20ÂI:1,225, ¯Å§O:20
¬¡°Ê:0%¬¡°Ê:0%¬¡°Ê:0%
 

³s±µ¤é´Á: 2006 ¦~9¤ë
¹L±b: 2
Cellbiogal RSS µ²Âà
¹L±b Monoclonal §ÜÅ骺¥Í²£- §Þ³N¦b·Æ¹«

§K¬Ì¾Ç§Þ³N

°µMonoclonal §ÜÅé




²¤¶

Monoclonal §ÜÅé¬O°¶¤jªº! ¬°¤°»ò? ¯S²§©Ê! ¨C¤@­Ó»{¥i¥u§Ü­ìµ²ºcªº¤@­Ó¯¸ÂI¡C¬°¤°»ò? ¤£¦´! ½è¶q¤å¤Æ¥i¯à³Q¥Í¦¨±q°ß¤@§J¶©¡C

·Æ¹«¤p! ¥L­Ì­n¨D¸û¤Ö§Ü­ì¤ñ¨ß¤l±o¨ì§ÜÅé¦^À³¡C§Ü­ì¹C¹M´`Àô¨t²Î¡C¦å²G¶}¤ô¹D³q¹LB ²O¤Ú²Ó­M¹q¦À»{¥i¥~³¡¾÷Åé©M¥Í²£§ÜÅ骺µÊŦ¡C

µÊŦ¹q¦À, µM¦Ó, µLªk³æ¿W¥Í¦s¦b²Õ´°ö¾i°ò¡C°©Åè½F¹q¦À¯à! ¬°¤°»ò¤£º²¤Æ¥L­Ì?

§Ú­Ì¯à¿ï¾Ü¬°³Qº²¤Æªº¹q¦À¥Ñ¨Ï¥Î´U¤l(hypoxanthine ¡Baminopterin, thymidine) ³Q¸É¥Rªº´CÅé¡C¬ðÅÜÅé°©Åè½F¹q¦À½u¸ôSP2/0 µLªk¥Í¦s¦b´U¤l´CÅé¦]¬°¥¦¯Ê¥FHGPRT ¡Caminopterin ¦b´U¤l¸É¥R±ø´ÚªýÄdDNA ºî¦X¡C»Ã¯ÀHGPRT ¥i¯à§JªA³o­Ó¶ô¡CµÊŦ¹q¦À¦³HGPRT ¡Cº²¤ÆµÊŦ¨Ã¥BSP2/0 ¹q¦À©M±z±N§ä¨ì­Æ¦sªÌ¦b´U¤l²Õ´°ö¾i°ò¡C




ª`:

°O¦í, ¤£¨&ªº§Þ³N!

¬~º°yo ' ¤â¡C

¦pªG±z¶É¦R(±zÀ³¸Ó¯u¥¿¦a§l¨ú) ¤£·¸¥X! ¦¾Â©µo¥Í¥Ñ©ó·¸¥X¦b²~©MºÞ¥~­±¡C¹ï®ò°ò­f¥Ò»Ä¤G©M¤õµK·í±z·P¨ì°¾°õ¡C

¬°±z¦Û¤vªº¦w¥þ©Ê, ¬ïÀ¹¤â®M·í¸Ñ­å¡C

¨Ï¥ÎdisPo ²£«~Á×§K¦³¬~º°¾¯´Ý·ºªº°ÝÃD¦b³Q¬~º°ªº¬Á¼þ¾¹¥×¡C




¥Î«~:

BALB/c ¥À·Æ¹«¬°§K§Ð

¤@¶ô·Æ¹«/¹}¾iªÌ¼h

disPo §l¨ú- 10 ¾÷¾¹»y¨¥©M25 ¾÷¾¹»y¨¥

²Õ´°ö¾i²~(5/¹}¾iªÌ¼h)

24 ¦nªº²Õ´¤å¤ÆªO§÷(¤j¬ù12 ¨C¿Ä¦X)

3 ³Q¯uªÅ¥[¼öªº®MÆh¤l©M°Å¤M

1 ­Ó³Q¯uªÅ¥[¼öªº«Ì¹õ¬°µÊŦ¹q¦À¤À´²§@¥Î

5cc ª`®g¾¹(¬W¶ë³Q¨Ï¥Î¤À´²¹q¦À¦b«Ì¹õ)

1.cc ª`®g¾¹

18g & 25g (1/2 ­^¤o) °w

100 ¶ô²@¦Ì²Õ´¤å¤ÆªO§÷

15 & 50 ¾÷¾¹»y¨¥¤£¨&ªº¶êÀ@§ÎºÞ

* ¬Ý¨£ªþ¦³¬°¸Ô²Ó¸ê®Æ¦b©w³f




§K§Ð

§R¥h³J¥Õ½è½d³ò±qpolyacrylamide ½¦¾®Åé¡C

Coomassie ¦¾ÂI¤p®É& destain (10% ¤A»Ä, 45% ¥Ò¾J) ¾¨§Ö, °Å¤Á½d³ò·í¥L­Ì¬O¥iÃѧOªº­­¨î®É¶¡½¦¾®Åé¬O¦b»Ä¸Ì¡C¨R¬~»PPBSa & §R¥h¤F½d³ò¡C³J¥Õ½è¥i¯à³Q¦sÀx»P¤p¶qªºPBSa ¦b-20 §N­á¾÷¡C

¨Ï²Ä¤@®g¤J³J¥Õ½è¦b1:1 ¤ñ²v»PFreund ªº§¹¥þ©ÎTiterMax ¡C

1. ¨Ï³J¥Õ½è§¡¤Ã»P¤p¶qªºPBSa ¦]¦¹³J¥Õ½è¤£±o¨ì¤Ó«p¹ê¡C«O¯d³J¥Õ½è´H§N·í§¡¤Ã¡C

2. ¦pªG¨Ï¥ÎFreund ªº, ²V¦X¦ºªº²Óµß¦b²~¡C§âFreund ¤Þ¤Jªºª`®g¾¹©M±j¨î¥¦¤J¤@­Ó¤p¿NªM¥]§t±zªº³J¥Õ½è½d¨Ò¡C²V¦XFreund ªº©M±zªº³J¥Õ½èª½¨ì¥¦©Ó¾á¥Õ¦âªwªj¦üªº¤@³e©Ê¡C±z¥i¥H¥²¶·§ó´«°w©Mª`®g¾¹¦]¬°Freund ªº°_¤ÏÀ³»P¶ì®Æ¡C

§Yª`®g6 ­Ó·Æ¹«¥Hemlc ©Mrmlc ¨C­Ó, §Ú¹B¦æ¤@12% ½¦¾®Åé, §R¥h¤F½d³ò, §¡¤Ã³J¥Õ½è©M»PFreund ªº450ul ³Qµ²¦X¦U­Ó³J¥Õ½è½d¨Ò¡C³oµ¹§Ú¤Ö³\600ul ¦U­Ó½d¨Òª`®g¡C

3. ª`®g¡C°Ñ¨£°Êª«Å@¾i«ü«n¬°§ó¥[¶i¤@¨Bªº«ü¥O¡C




ª`:

� ª`®g100ul ¨C·Æ¹«¡C

� ±zªº½d¨Ò¥²¶·³Q¶°¤¤¦ý¤£¨º»ò¿@«p, ±zµLªk±o¨ì¥¦³q¹L¤@1/2 ­^¤o, 25g °w¡C

� ¤£¨&¬O­«­n¬°·Æ¹«ªº°·±d!

¤G­Ó¬P´Á¥H«á, °µ²Ä¤G®g¤J³J¥Õ½è»PFreund ªº¥¼§¹¦¨»²ÃÄ©ÎTiterMax ¡C

¤G­Ó¬P´Á¥H«á, °µ´ú¸Õº¯º&¡C¦pªG­tªº, °µ¨ä¥¦´£°ª»PFreund ªº¥¼§¹¦¨»²ÃÄ©ÎTiterMax ¡C

¤­­Ó¤é¦b¿Ä¦X¤§«e, °µ³J¥Õ½è³Ì²×´£°ª¨S¦³Freund ªº¡C




´ú¸Õ¬y¦å

¼Ð°O·Æ¹«ªº§À¤Ú¡C

¾A¥Î©óªo»I§À¤Ú(­±¿nªº3/4 ­^¤o, ±q°ò¦©¹­n³Z) ¡C

¨Ï¥Î·¥ºÝ¾W§Qªº¤M¤ù°µ¤ù¦¡(EM ¤M¤ù) ¡C¤p¤ß¤£¬ï¹L§À¤Ú¥u¬O¨Ï°Å¤Á¨¬°÷¤jµe¤j¬ù2.5 heprinized ¦åµ·ºÞ¡C

¬I¥[À£¤O¨n±é³Ð¶Ë²×¤îÆFµß¡C

Âà°Ê¦b¦å²G¤U¥H³Ì¤j³t«×5 ¤ÀÄÁ¦bmicrofuge ¡C

ºM°h©M¦sÀx²M²G¦b-20o ª½¨ì±z¯à´ú¸Õ¦b¦¾ÂI¦b1:100 ©Î¦b1:50 ¡C




·Ç³Æ¬°¿Ä¦X¤é

WED/THURS

¸Ñ­á¦bSP2/0 ¤§¥~ªO§÷, ¤Àµõ¤F¤@¨ì3. (¥²¶·¤Àµõ¦b¶g¥½´Á¶¡) ¡C»Ý­n10-12 100mm ªO§÷¦b¤é»x¶¥¬q¬°¿Ä¦X¡C

§Ö³t¸Ñ­áºÞ¦b37o ¯D¡C§ë¤J¤Jfalcoln ºÞ»P·Å·xªº´CÅé10ml ¡CÅý§¤5 ¤ÀÄÁ¡CÂà°Ê¤U¨Ó¦b§C³t¡C­«·sÄa±¾¦b10 ¾÷¾¹»y¨¥©MÂà°Ê¡C­«·sÄa±¾¦b30ml ©M§ë¤J¤J3 ¶ôªO§÷¡C

THURS

¹B¦æ½¦¾®Å鬰³Ì²×´£°ª¡C

¬P´Á¤­

°µ³J¥Õ½è³Ì²×´£°ª¨S¦³Freund ªº©ÎTitermax ¡C

¬P´Á¤@

·Ç³Æ¹}¾iªÌ¼h

TUES

°µ¿Ä¦X!

¹}¾iªÌ¼h¤é

¦¬¶°

°Êª«¸³¨Æ·&ethanoled ©MµM«á®øª¢¤F¦bµµ¥~¥ú¤§¤U

2 x 10 ¾÷¾¹»y¨¥³­´À¦¡°ö¾i¥×

³Q¯uªÅ¥[¼öªºÆh¤l¡B°Å¤M, & «Ì¹õ

5 ¾÷¾¹»y¨¥ª`®g¾¹, 10 ¾÷¾¹»y¨¥ª`®g¾¹, 18g °w

¿NªM»P95% ¹ï®ò°ò­f¥Ò»Ä¤G

disPo 10 ¾÷¾¹»y¨¥§l¨ú

·Å·x¥H¤U¦b37o ¼ö¤ôÁç:

� 50 ¾÷¾¹»y¨¥¾ã°£¼ÆDMEM- ¨S¦³ªþ¥[

� ¤U¦C³Q²K¥[¤Fªº500 ¾÷¾¹»y¨¥²~DMEM ¤G:

5 ¾÷¾¹»y¨¥¶u¤þà¬»ÄÆQ

5 ¾÷¾¹»y¨¥L glutamine

HAT(with ª`®g¾¹, ¬¦®ú5ml DMEM ¤J´U¤l²~, ²K¥[¨ÓDMEM)

5 ¾÷¾¹»y¨¥anti-biotic/anti-mitotic (¤£­n·Å·x³q¹L«ÇÁ{®É)

50 ¾÷¾¹»y¨¥Hyclone ­L¨à¤p¤û²M²G

§ë¤J¤J5 x 50 ¾÷¾¹»y¨¥¶êÀ@§ÎºÞ(¥H«á½Õ¥Î¨ì5 ­Ó¿N²~¬°¹}¾iªÌ¼h) ¡C

� ³]¸m¤£¨&ªº¸Ñ­åªº¾¹ª«¡C

� ±o¨ì¥¿±`un-immunized ·Æ¹«¡C

� ¦w¸m«Ì¹õ¦bªO§÷¸Ì¥H10 ¾÷¾¹»y¨¥DMEM - ¡C

¸Ñ­å

¤u§@§Ö³t! (§óºCªº±z¬O, §ó¥[§xÃøªº¥¦¬O¤u§@»P°Êª«¡C¨Ã¥B, ±z¤£­n´CÅé§N«o¡C)

� Ä묹·Æ¹«¡C¹ï®ò°ò­f¥Ò»Ä¤Gª½¨ì¹¡©M¡CPin °Êª«¨ì¦ì¡C

� ¨Ï¥Î¤@®M¾¹ª«¬ï¹L¥Ö½§, °wªð¦^¾×¤ôªO¡C¹ï®ò°ò­f¥Ò»Ä¤G!

� ¨Ï¥Î¨ä¦¸³]¸m¾¹ª«¹ï°Å¤Á³q¹L¸¡½¤¡C

� ¨Ï¥Î²Ä¤T³]¸m©Þ¥XµÊŦ, °Å¤Áµ²½l²Õ´¡C

§ó´«¾¹ª««D±`­«­nÁ×§K¦¾Â©¡C

¬~º°¹q¦À

� §Ö³t§ë¤JµÊŦ¦b½L¥H10 ¾÷¾¹»y¨¥DMEM - ¡C©M¥J²Ó¦a¤À´²µÊŦ¹q¦À»P¤@­Ó5 ¾÷¾¹»y¨¥ª`®g¾¹ªº¬W¶ë¤Ï¹ï«Ì¹õ¡C

� ¯d¤Uµ²½l²Õ´¦bºô®æ, ¤W¤W¤U¤U§l¨ú©M§ë¤J¹q¦À¤J15ml ¶êÀ@§ÎºÞ¡CÅý¤j¤j¶ôµ²ºâ¹ïºÞªº©³¼h2-3 ¤ÀÄÁ¡C

� ½Õ¥Î¤W¼h²M²G¨ì¨ä¥¦ºÞ±a¨Ó¼Æ¶q15 ¾÷¾¹»y¨¥»P§ó¦hDMEM- µ¹¬~º°¡CÂà°Ê¤U¨Ó10 ¤ÀÄÁ¦b170g ¦b»O¦¡Â÷¤ß¾÷¡C

� ¥J²Ó¦a, §m¤W¼h²M²G»P¤£¨&ªºpasteur §l¨ú¡C¦A¬~º°µÊŦ¹q¦À»P10ml DMEM - ¡C

� §m¶W¯Å¡CResusp ¡C¦b5ml DMEM -, ¹å¤Æ10 min. ¦b37o ¯D¡C¶É¦RDMEM+ 5x 50ml conicals ¤Jtc ¿N²~¡C§ë¤JµÊŦ¹q¦À1ml ¦b¦U­Ó¿N²~¸Ì¡C

� ¹å¤Æo/n ¦b6% ¤G®ñ¤ÆºÒ37o ¤À®x¡C©ñ¸m¿N²~¦bÃä»P»\´UÃP¶}¡C

¿Ä¦X¤é

I. ¦¬¶°§K¬ÌµÊŦ¹q¦À¡C

II. ¦¬¶°SP2/0 ¹q¦À¡C

III. »P¹}¾iªÌ¼hµ²¦X¡C

¦¬¶°

� ©Ò¦³¦P¼Ë¥Î«~³Q¨Ï¥Î¬°¹}¾iªÌ¼h¦b¤é«e¡C

� ½Õ¥Î50% °v¤J¤@¤ä¶êÀ@§ÎºÞ¡C

� ·Å·x°v¡B¬~º°´CÅé, ©M´Ý¾lªºDMEM+ ¦b37o ¼ö¤ôÁç¡C

¸É¥Õ®øª¢´Ý¾lDMEM+ ´CÅé±q³Q¹}¾iªÌ¼h¬Q¤Ñ¸òÀH¡C¹}¾iªÌ¼h¬O¥i¯à°ô¶ë¸É¥Õ¡C(½T©w±z¦³´CÅé¦b®e¾¹¦bÂà°Ê¦b¯uªÅ¤§«e±z¯à§_«h¶Ë¸É¥Õ½¤) ¡C

·Ç³Æ§K¬ÌµÊŦ¹q¦À

¸òÀH¨óij¨Ï¥Î¸Ñ­å·Æ¹«¬°¹}¾iªÌ¼h¡C

¥¦­«­n¨Ï®É¶¡´î¨ì³Ì¤p, µÊŦ¹q¦À¬O©Î¤£¬O¦b°Êª«©Î¤£¬O¦b¹å¾i¾¹¡C¦]¦¹©M®Ú¾Ú¦h±z§Ö¯à¸Ñ­å·Æ¹«, ±z¥i¥H·Q­n­º¥ý¦¬¶°SP2/0 ¹q¦À¡C

¦¬¶°SP2/0 ¹q¦À

Triterate ¹q¦À±q10 ¶ôªO§÷©M§ë¤J¤J2 x 50 ¾÷¾¹»y¨¥¶êÀ@§ÎºÞ¡C

±ÛÂà¦b¹q¦À¤U¡C¬~º°¹q¦À2x. ÃĤY10 min. ¦b170g ¡C
®gÀ»µÊŦ¹q¦À·ítriterating SP2/0 ¹q¦À
resusp µÊŦ¹q¦À, ¬~º°, ÃĤY·íÃĤYSP2/0 ¹q¦À
resusp µÊŦ¹q¦À, ¬~º°, ÃĤY·íresusp ¤@­ÓºÞ¦b5ml, ½Õ¥Î

¨ä¥¦ºÞ, ¬~º°, ÃĤY
resusp µÊŦ¹q¦À¦b10 ¾÷¾¹»y¨¥, ­p¼Æ, ·íresusp SP2/0, ¬~º°, ÃĤY

Åý§¤10 ¤ÀÄÁ¦b37o

resusp ¦b20-30 ¾÷¾¹»y¨¥, ­p¼Æ
1 ­Óx 108 ­ÓµÊŦ¹q¦À²K¥[¨Ó5 x 107 SP2/0 ¹q¦À

� ÃĤY¹q¦À¤@°_¥H§ó°ªªº³t«×(¦b170 ¤§¶¡- 200g) ¡C

� §m´CÅé

� ²K¥[1.5 ¾÷¾¹»y¨¥°v1 min. ¦b¹ª°Ê¤§¤U-- ³o¬O¿Ä¦X!!!

ÅͰʥH­n³Z¬X©M¦a§l¨ú²V¦X¦b°v

� µ¥«Ý90 ¬í, ¬X©M¦aÅͰʡC

� ¦b¤U¤ÀÄÁ´Á¶¡, ²K¥[³Q·Å·xªºDMEM- 1ml ·íÅͰʡC

� ­«½Æ¦­¥ý¨BÆJ¡C

� ²K¥[8 ¾÷¾¹»y¨¥DMEM- 5 ¤ÀÄÁ¡C

� µ¥«Ý10 ¤ÀÄÁ¡CµM«á, ¥´¶Ã¹q¦À¥Ñ¬X©M¦a§l¨ú5 ¦¸¡C

� µ}ÄÀ¤J¤£¨&filterized DMEM+ ¥H¹}¾iªÌ¼h¡C

� ¾ã°£¼Æ2ml/ «Ü¦n¦b24 ¦nªºªO§÷(~ 10-12 ªO§÷¸Ì)

� ¹å¤Æ¦b6% ¤G®ñ¤ÆºÒ, 37o ¤À®x¸Ì¬°¤@­Ó¬P´Á¡C

� ­÷¾i©M¹å¤Æ¦b~one ¬P´Á¡C

¼f¬d

¤@­Ó¬P´Á¦b²Ä¤@´CÅé­÷¾i¥H«á:

´ú¸Õ´CÅéÂà°Ê¶À¦âªº¤«¡C

ºM°h500ul & ¹ï¦¾ÂI¤p±øªº´ú¸Õ, ¹j©]¹å¤Æ¡C(¤£­n§Ñ°O¥¿±±¨î¥]¬A·Æ¹«§ÜÅé- ¨Ï¥Î·Æ¹«polyclonal ²M²G©M¤@­Ó¼Ð°O¡C)

ªø¤j¥¿¤«¦b§ó¤jªºªO§÷¸Ì¡C

¦A¹êÅ礫©M¨ä¹ïÀ³ªºªO§÷¡C

¨â­ÓÀ³¸Ó¬O¥¿¡CÄ~Äò¤Àµõ¥¿ªO§÷©M­áµ²¤U¨Ó(¦b10% DMSO) ©M¤W¤É¡CTriterate ©Mµ}ÄÀ¹q¦À±q¥¿¤J¤@¶ô96 ¤f¤«ªO§÷¦b1 ­Ó¹q¦Àªºµ}ÄÀ¹ï~3 «Ü¦n´é¥X¡C§Ú­Ì¦V°ß¤@§J¶©¨D§U!

½Õ¥Î¹q¦À¦b96 ¶ô¦nªºªO§÷¹ï24 ¦nªºªO§÷©M­«´ú¡C

¦A³q¹Lµ}ÄÀª½¨ì©Ò¦³¤«´ú¸Õ¥¿¨Ã¥B±z³Q»¡ªA±z¦³¤@±ømonoclonal ¹q¦À½u¸ô¡C

³Ì²×, ¹Á¸Õ©MÂ_µ´¹q¦À±q10% FCS ¨ì5% FCS, ©M±q´U¤l¨ìHT ¹ïunsupplemented ´CÅé¡C

IgG ªº¿Ë¦X¤O¬~²b¨Ï¥ÎG ¤p¯](Pharmacia)

½w½Ä:

0.1M NaPO4, »ÄÆP«×7.0

¤@»ù- 5.52g ¦b200 ¾÷¾¹»y¨¥¬°0.2M ¤@»ù

¤G¤¸- 8.52g ¦b300 ¾÷¾¹»y¨¥¬°0.2M ¤G¤¸

¶}©l¥Î¤G¤¸¸Ñ¨M¤èªk©Mºw©w¶q»P¤@»ùª½¨ì»ÄÆP«×7.0 ³Q¨ì¹F

¥Î¤ôµ}ÄÀ1:1 ¦Ü©ó¨Ï¥Î

1.0M ¤A»Ä- 0.1M ®ò°ò¤A»Ä½w½Ä, »ÄÆP«×3.0

30.12 ¾÷¾¹»y¨¥¤A»Ä

3.75 g ®ò°ò¤A»Ä

±a¨Óµ¹500 ¾÷¾¹»y¨¥¥Î¤ô

¨óij

1. ¥­§¡¦C¥H´X­Ó»ÄÆP«×7.0 ½w½Äªº¼Æ¶q¡C

2. §ë¤J½d¨Ò¦b¦C- 10 ¾÷¾¹»y¨¥¨ß¤l²M²G¬°IgG ¹jÂ÷©Î¤ì¥Ê®ø¤Æªº¾ã­Ó¼Æ¶q- ±Ä¨ú½¦¾®Åé½d¨Ò¡C(¬y³t¥H1mL/4 ¤ÀÄÁ)

3. ¤§¥~³q¹L- ¦b¤ì¥Ê¤åºK¸Ì³q¹L³q¹L¥]§t«Ü¦n- ³q¹L±Ä¨ú½¦¾®Åé½d¨Ò¡C

4. ¬~º°¹ï¯óÀÀ¥H»ÄÆP«×7.0 ½w½Ä(1-2 ®É¼Æ) ¡C

5. ¬~²æ¥H»ÄÆP«×3.0 ½w½Ä- §@¬°15-20 ¤ÀÄÁ¬Ý¬Y¨Æ¡C

6. ¦¬¶°0.5 ¾÷¾¹»y¨¥¤À¼Æ©M¤¤¥ß¤Æ¸Ñ¨M¤èªk»P1.0M Tris ¹ï»ÄÆP«×7.4 (¥Î³~«ü¥Ü²Å¤p±ø) - ±Ä¨ú½¦¾®Åé½d¨Ò¡CSpec ¤À¼Æ¬d§ä®p³»¡C

7. ¬~º°¥H»ÄÆP«×3.0 ½w½Ä15 ¤ÀÄÁ©M¦sÀx¦b20% ¹ï®ò°ò­f¥Ò»Ä¤G¸Ì¡C

8. ¹j©]º¯ªRIgG ©Î«Ü¦n¤Ï¹ï4L PBS ¦b4� C µM«á¦b«Ç·Å¥H2 §ó§ï1-2 ­Ó¤é¡C

9. ½T©w¿@«×¨Ï¥Îspec ¦babsorbance 280nm »PA280 1.35 ¬°IgG ©Î1.5 ¬°«Ü¦n¡C

10. ¦sÀx¦b-80� C ¦b¾ã°£¼Æ¡C




§Ü¦å²Mªº¿Ë¦X¤O¬~²b¨Ï¥ÎDPT ¯È

1 ¡C¹B¦æSDS-PAGE µ¡©©¡C(¥Î³~¦P¼Ë¦h³J¥Õ½è¾¨¥i¯à¨S¦³«D±`¦³±z«_ÀI¤@°_¹B¦æ½d³ò©Mªg¬V½d³ò§Q¯q) ¡C

2. ¦w¸m¥¼ªg¦¾ªº½¦¾®Åé¦b0.5 M KCl ¸Ì10-15 ¬í-- ª½¨ì½d³ò¶}©l¥X²{¡C½d³ò±N¬Ý¤W¥h½T¤Á, ·í½¦¾®Å骺³Ñ¾l±NÂà°Ê¥Õ¦â§@¬°SDS ¨I¾ýª«¡C¥h°£½¦¾®Åé¤@¶ô¬Á¼þªO©M¾¨§Ö§R¥h½d³ò§Q¯q¡C¦pªG±z¤Óªø´Áµ¥«Ý, ½d³ò±NÂà°Ê¥Õ¦â¡C

3. ¦w¸m½¦¾®Åéstrip(s) ¤J50 ²@¦ÌNaPO4, »ÄÆP«×6.5 ¥H0.1% SDS ©Mº}¬~3 ¦¸, ¥H¬X©M¾_°Ê, 30 min. ¨C¨R¬~¡C

4. ¦b²Ä¤T¦¸½¦¾®Åé¬~º°, ¶}©lAPT ¯Èªº°_°Ê¡C°µ³o¨Ç¨BÆJ¦b§N«Ç¦b¦B¯D¡C­º¥ý, ¦w¸m¾A·í¤j¤pªº±i(»´·L¦a¤j¤ñ½¦¾®Åé) APT ¯È¦b§Nªº1.2N (100 ¾÷¾¹»y¨¥) ³Q²K¥[¤F3 ¾÷¾¹»y¨¥¶u¨Èµv»ÄÆQªºHCl (NaNO2) ¡CNaNO2 ³Q°µ¦b¤ô¤¤¦b10 mg/ml ¦b¥Î³~«e¡C¹å¤Æ¯È¦b¦B»Poccassional ¾_°Ê15-30 ¤ÀÄÁ¡C¥»¤åÀ³¸ÓÂà°Ê©ú«Gªº¶À¦â¡C°_°Ê³Q¤G¸òÀH©Î§ó¥[¨³³tªº¦B¤ô¬~º°©M¤G¦¸¨³³t¬~º°¥H50 ²@¦ÌNaPO4 »ÄÆP«×6.5, »Ý­n5 ¤ÀÄÁ¬°¾ãÅé¶iµ{¡C(·í§Ú­ì©l°µ¤F³o, §Ú¨Ï¥Î¤F­n¨D5 ¦¸X 5 ¦¸©P¸Ô¬~º°¥H¦B§N¤ô©M¤@¦¸ÀH«á10 ¤ÀÄÁ¬~º°¦b´H§N50 ²@¦ÌNaPO4 ªº¤@­Ó¨óij, »ÄÆP«×6.5 ¡C¦ý¬O, ¥Íª«ÀH¾÷¦s¨úºÏºÐ±j½Õµuªº¬~º°¥²­n¡C¨â­Ó¦ü¥G¹B§@¬°§Ú¡C)

5. ¦b°_°Ê¤§«á, ³]¸m½Õ¥Î¦b´H§N¨Ï¥Î50 ²@¦ÌNaPO4, »ÄÆP«×6.5 ¦p¦P½Õ¥Î½w½Ä¡C½Õ¥Î4 ®É¼Æ¦b0.6 ¦w°ö(Hoefer TE-52) ¡C¥»¤åÀ³¸ÓÂà°Ê¤Forangey (®ç¤l) ÃC¦â¡C½¦¾®Åé¬OªºUsusally, ÃC¦â¬O§ó»´ªº¡C

6. ªýÄdDPT ¯È¦b¥H¤U½w½Ä2 ©Î§ó¦h®É¼Æ:

0.25% ©ú½¦(0.5 g) ­º¥ý·»¤Æ¥Ñ¼ö¤Æ

20 ¾÷¾¹»y¨¥®ò°ò¤A¾J

20 ¾÷¾¹»y¨¥1 M Tris-HCl »ÄÆP«×9.0

_______________________

¹ï200 ¾÷¾¹»y¨¥»PdH2.O

7. ¨R¬~¼sªx¦b"½w½Ä1" ±q¨ÆªýÄdªº¨BÆJ¡C°µ¦Ü¤Ö3 20-30 ¦¸¤ÀÄÁ¬~º°¡C

½w½Ä1:

50 ²@¦ÌTris-HCl, »ÄÆP«×7.5

5 ²@¦ÌEDTA

150 ²@¦ÌNaCl

8. Àˬd½Õ¥Î®Ä²v, «d´î¤p±øªºDPT ¯Èªº¤@Ãä¨ì³J¥Õ½è½Õ¥Î¤F¨Ã¥B¹å¤Æ»P±zªº(¾A·í¦a³Qµ}ÄÀªº) §ÜÅé¹j©]¡C(µ}ÄÀ§ÜÅé¦b½w½Ä1 ¥]§t0.25% ©ú½¦, ©Î1% BSA [ ´µ®æ½X¤À¼Æv ] ¡C§Ú¨Ï¥ÎBSA ¡C) ºû«ù¥H¥¿±`¨óij¬°immunobloting, §Yº}¬~(½w½Äªº3 §ó§ï1 ©ÎPBS) 30 ¤ÀÄÁ, ¹å¤Æ2-4 ®É¼Æ¦bperoxidase ³Q¦@³mªºªþÄݧÜÅé, º}¬~, Åã²{¥X¦b0.05% 4 chloro 1 napthol (À±¸É§@¬°¤@­Ó0.3% ¸Ñ¨M¤èªk¦b¥Ò¾J¸Ì), 0.01% H2.O2 ¦bPBS ¡C¦^À³¬Ý¦b¬Ý¨£¦bµv¤ÆÅÖºû¯ÀªºDPT ¯È³q±`¤£¤@¼Ë¤À©ú¹³¡C

9. ¦pªG±zµ¥«Ý¥H«eÀˬd½Õ¥Î®Ä²v¨Ï¥ÎDPT ¯È, ¥¿¸q¦sÀx¯È¦b½w½Ä1 ¦b4.o C ª½¨ì¥Î³~¡C

10. ¨Ï¥Î§Ü­ì¸õ°_DPT ¯È:

a. °Å¤Á¤F¯È¦¨¤p¥¿¤è§Î(¦b¤@¶ô¬Á¼þªO) »P¤@­Ó°®²bªº«cޤM¡C

b. ¦w±ÆÂ\¥¿¦b10 ¾÷¾¹»y¨¥ª`®g¾¹¸Ì»P¤j´ú¶q»ö°w

c. ¹å¤Æ¥H§Ü¦å²M(§Úªº¾A·íªºµ}ÄÀªº5 ¾÷¾¹»y¨¥¨Ï¥Îµ}ÄÀ2 ­¿³Q¶°¤¤¤ñ¨º³Q¨Ï¥Î¬°immunoblotting) ¡Cµ}ÄÀ³Q°µ¦b½w½Ä1 »PBSA ©Î©ú½¦¡C¹j©]¹å¤Æ¥H»a«l¾_°Ê¡C§Ú°µ³o¦bR.T. ¨S¦³¥ô¦ó°ÝÃD

d. ²Ä¤G¤Ñ¦­±á, ¼Q¦b³Qµ}ÄÀªº§Ü¦å²M¤§¥~(±q­þepitope ¯S©w§ÜÅé¾Ú±À´ú³Q¥h°£¤F) ¨Ã¥B§â¤j¬ù10 ¾÷¾¹»y¨¥½w½Ä¤Þ¤J1 ª`®g¾¹¡C¨³³t¦a¾_°Ê©M­«½Æ¬°¤@­ÓÁ`ÃB3 ¨R¬~(30 ¤ÀÄÁ¨C­Ó)

e. ¬~²æ¯S©w§ÜÅé, ¨Ï¥Î4 ¾÷¾¹»y¨¥5 M NaI ³QÀ±¸Éªº·sÂA¦b¦B¸ÌH2.O ¡C¤Äµe¤Jª`®g¾¹©M¦w¸m¦b¦B; ¹ª°Ê¥Ñª`®g¾¹ªº¦ÛÂà¦b¦B8 ¤ÀÄÁ

f. ±j¨îNaI ¸Ñ¨M¤èªk(²{¦b¥]§t³Q¬~²æªº§ÜÅé) ¤JºÞ(50 ¾÷¾¹»y¨¥ÂyÆNÃþ«¬) ¥]§t600 ½w½Äll 1/1% BSA ¡C¤@¦A±j¨î½w½Ä1 ³q¹LDPT ¯È, ¦X¨Ö©Ò¦³³o¨Ç¬~º°¦b¦P¼Ë50 ¾÷¾¹»y¨¥ºÞª½¨ì¤@­ÓÁ`ÃB40 ¨ì50 mls ³Q¨ì¹F¡C(±z¥i¥H¥²¶·µ}ÄÀ§ó¥[¶i¤@¨B¦pªG¹ï§ÜÅ骺·N±ýªº¥Î³~¬O¬°¿Ã¥ú§K¬ÌÀËÅçªk¡C¬O¤Ó°ªÆQªº¿@«×¤z¯Aº·¥ú§Î¶H¤Æ) ¡C

g. ¶°¤¤§ÜÅé:

´À¥N# 1 ¡C

¶°¤¤¨Ï¥ÎMillipore ¥i®û¤JªºCX-10 ¸É¥Õ¡C·Ç³Æ¸É¥Õ¥Ñº}¬~¥ÎdH2.O ©MµM«á¹LÂo³q¹L¤j¬ù5 ¾÷¾¹»y¨¥1% BSA/Buffer 1 ªýÄd¯¸ÂI(¨¾¤î¥¼«ü©úÂHªþ¹ï¸É¥Õ) ¡C¶°¤¤¤U¨Ó¹ï2-4 mls, ®Ú¾Ú±zªº§ÜÅé, µ¹³Ì²×¹B§@ªºµ}ÄÀ¬°immunoblotting ¡C¦pªG»Ý­n, ¶i¤@¨B¶°¤¤¬°¿Ã¥ú§K¬ÌÀËÅçªk, ©Î¬°µ}ÄÀ¥HªýÄdªº½w½Ä(§Y5% ±d¤DÄɥߧY¤û¥¤) ±zªº¿ï¾Ü(¬°immunoblotting) ¡C

´À¥N# 2. (§Ö³t¦a)

a. ·Ç³Æ¤Gamicon centricon ¸É¥Õ(30,000 ¥ü¥Ë¤Á°£) ¥Ñ²K¥[300 ¾÷¾¹»y¨¥½w½Ä#1 1% BSA ¡C

b. ¦w±Æ¤@­Ó¤@¥b5M NaI/antibody ¸Ñ¨M¤èªk¦b¨C­Óªº¤W³¡¤ô®w¤Gcentricon ¸É¥Õ¡C¨Ï¥Îpasteur §l²¾ºÞ, ÅͰʲV¦X¤G­Ó¸Ñ¨M¤èªk¡C

c. ±ÛÂà¦b5000 x g 30 ¤ÀÄÁ¡C(¥Î³~parafilm °µ¸É¥Õ¾A¦X¤J¹q°Ê¤l¾A°t¾¹¡C

d. ¦b±ÛÂà, ©ñ±ó³q¹L¤F¸É¥Õªº²GÅ餧«á(§Y²GÅé¦b§ó§Cªº¤ô®w) ¡C

e. ±a¨Ó²GÅé´Ý¾l¦b¤W³¡¤ô®w(100-500 ¾÷¾¹»y¨¥) µ¹2 mls ªº¼Æ¶q¥H½w½Ä1 ¡C

f. ±ÛÂà¦A¦b5000 x g 30 ¤ÀÄÁ¡C

h. ³q¹L¤F¸É¥Õªº©ñ±ó²GÅé¡C

i. ²K¥[250 ¾÷¾¹»y¨¥½w½Ä1 ¨Ó¦U­Ó¤W³¡¤ô®w©M»\´U»P¦s¶J¤ô®w¡C

j. ­Ë¸mºÞ©M±ÛÂà¦bªí¸Ì¤ÀÂ÷2-3 ¤ÀÄÁ½Õ¥Î¾ã­Ó½d¨Ò¤J¦s¶J¤ô®w¡C

NB. ¸É¥Õ¥i¯à³Q­«·s¨Ï¥Î¬°¦P¼Ë§ÜÅ骺³Q­«½Æªº¬~²b¡C¦sÀx¦b«Ç·Å¥H1 ¾÷¾¹»y¨¥½w½Ä1 ¦b¤W³¡¤ô®w¡C

11. ¦sÀxDPT ¥¿¤è§Î¦bª`®g¾¹¦b½w½Ä1 ¦b4.oC ¡C§Ú¨Ï¥Î¤F­¡´á¦ý¤@¦A±q¥¼¨Ï¥Î¤F¥¿¤è§Î(10-12 ¦¸) ¦b6 ¤ë¥÷¤¤¨S¦³¥ô¦ó°ÝÃD¡C

Immunoprecipitation

1. ¦¬Ã¬5 x 106 - 4 x 107 cells/sample ®Ú¾Ú«ç¼ËÂ×´I±zªº³J¥Õ½è¬O¡C¨Ï¥Î5 x 106 cells/sample ¹ïIP ¦Ù²y³J¥Õ, 4 x 107 cells/sample ¹ïIP dynein, ¨Ò¦p¡C¬~º°¹q¦À¨â¤T¦¸¦bDB, ©M­«·sÄa±¾¦b500 m l DB/sample ¡C¦w¸m¦b¦B¡C

2. ²K¥[¬Ûµ¥ªº¼Æ¶q2X IP ½w½Ä(¨Ï·sÂA) ¨Ã¥B²V¦X¦b¦B:

2X ½w½Ä¬°dynein IP:

100 ­Ó²@¦ÌºÞ¹D, »ÄÆP«×7.5

2% NP40

10 ²@¦ÌEDTA

50 ²@¦ÌNaPPi

200 ²@¦ÌNaF

5 ²@¦ÌDTT

2 ²@¦ÌPMSF

100 m g/ml leupeptin

100 m g/ml pepstatin

2 ²@¦ÌATP

2X ½w½Ä¬°¦Ù²y³J¥ÕIP:

40 ²@¦ÌTris, »ÄÆP«×7.5

0.2% NP40

2 ²@¦ÌDTT

10 ²@¦ÌEDTA

2 ²@¦ÌPMSF

200 m M TPCK

200 m M TLCK

20 ²@¦ÌNaHSO3

50 ²@¦ÌNaPPi

200 ²@¦ÌNaF

2 ²@¦ÌATP

200 ²@¦ÌKPO4

3. ²K¥[100 m g/ml RNAse A ¡C

4. ¤ÀÂ÷lysate 18K, 30 ¤ÀÄÁ, 2 «×, ¦bSS34 ¹q°Ê¤l¸Ì

5. ¦¬¶°³Q²M°£ªºlysate ¡C¨Ï¥Î1 ¾÷¾¹»y¨¥lysate ¨CIP ½d¨Ò¡C²K¥[¥D­n§ÜÅé:

¬°NW127 dynein HC Ab, ²K¥[50 ul serum/sample

¬°142, 143, 144 dynein IC §l¦¬, ²K¥[50 ul serum/sample

¬°9E10 anti-myctag Ab, ²K¥[200 ul supernatant/sample

¬°396 ¦Ù²y³J¥ÕAb, preincubate 25-30 m l GammaBind ©Î³J¥Õ½èsepharose ¤p¯]¥H1 ¾÷¾¹»y¨¥396 ¤W¼h²M²G4 ®É¼Æ¹ï¹j©]¡C¤U­±¬~º°¤p¯]¥¿¦p¨C¨BÆJ10-11 ©M­«·sÄa±¾¤p¯]ª½±µ¦a¦b1 ¾÷¾¹»y¨¥³Q²M°£ªºlysate ¡C¸õ¹L¨BÆJ6-7 ©M¶i¤Jª½±µ¦a¨BÆJ8 ¡C

6. ®Ì°Ê¦b§N«Ç2 ®É¼Æ¹ï¹j©]¡C

7. ²K¥[25-30 ul ³J¥Õ½èsepharose ªd¼ß¬°¨ß¤l©M¶×²v¥D­n§ÜÅé; ²K¥[25-30 ul GammaBind ªd¼ß¬°·Æ¹«¥D­n§ÜÅé¡C

8. ®Ì°Ê¦b§N«Ç1-4 ®É¼Æ¡C

9. Âà°Ê¦b¤p¯]¤U¦b5K 2 ¤ÀÄÁ¦bmicrofuge ¡C

10. ¨C¦¸¬~º°¤p¯]¨â¦¸¥H1 ¾÷¾¹»y¨¥1X IP ½w½Ä»P1 mg/ml BSA (´î¤Ö­I´º, ½Õ¾ãIP ½w½Ä»ÄÆP«×¨ì7.0 ¹ï¬~º°) ¡C¦p¤W©Ò­zÂà°Ê¤U¨Ó¡C

11. ¨C¦¸¬~º°¤p¯]¨â¦¸¥H1 ¾÷¾¹»y¨¥1X IP ½w½Ä, »ÄÆP«×7.0 ¨S¦³BSA ¡C¦p¤W©Ò­zÂà°Ê¤U¨Ó¡C

12. ¦pªG»Ý­n, °µ¤@¦¸³Ì²×¬~º°¦b1X IP ½w½Ä»P0.5M NaCl ¡C³o¶i¤@¨B±N´î¤Ö±zªº­I´º¡C¦ý¬O, ¥¦±N­éÂ÷dynein IC HC ·í°µIPs »PNW127 Ab!

13. ¥h°£¬~º°½w½Ä©Ò¦³¸òÂÜ, ©M­«·sÄa±¾¤p¯]¦b20-30 m l 2X SDS ½d¨Ò½w½Ä¡CµNªm5 ¤ÀÄÁ¡CÂà°Ê¦b¤p¯], ­t²ü¤U¶W¯ÅSDS ½¦¾®Åé¡CIgG ­«ªºÃì¤l¹B¦æ¦b50 kd; IgG »´ªºÃì¤l¹B¦æ¦b22 kd ¡C

ª`: ¦pªG±z¦³«Ü¦h­I´º, ¥¦¤]³\À°§Upreincubate ³Q²M°£ªºlysate »P¤p¯](¨S¦³§ÜÅé!) ¨â¤T®É¼Æ§lªþ¦b¥ô¦ó¥¼«ü©úªº®¹¸j¤§¥~¡CÂà°Ê¦b¤p¯]¤U, ¦¬¦^lysate, ©M²K¥[¥D­n§ÜÅé¡CÄ~Äò¶i¦æ¨BÆJ5 ¡C

1/95, Trivinos




¯S©w¸Ô²Ó¸ê®Æ¬°¦Ù²y³J¥ÕIps

1 ¡C¹q¦À³Q¦¬Ã¬¤F©M³Q¬~º°¤F¦bµLCa2+ MES °§¾j½w½Ä(20 ²@¦ÌMES, 2 ²@¦ÌMgSO4) ¡C

2. ¦B§N2 x ¯f¶Õº¥°h½w½ÄµM«á³Q²K¥[¤F¨Ó¹q¦À¼È±¾¡C(40 ²@¦ÌTris Cl pH7.5, 0.2% NP40, 2mM DTT, 10 ²@¦ÌEDTA, 2 ²@¦ÌPMSF, 2 ²@¦Ì¹¥ªA, 200 m M TPCK, 200 m M TLCK, 20 ²@¦ÌNaHSO3, 100 m g/ml RNAse A, 50 ²@¦Ì¶uµJÁC»Ä, 200 ²@¦ÌNaF, 2 ²@¦ÌATP, ©M200 ²@¦ÌÁC»ÄÆQpH7.5)

3. ºx´õ©MµM«á¤ÀÂ÷30 ¤ÀÄÁ¥Hmicrofuge ªº³Ì°ª³t«×¡C

4. ¤W¼h²M²G½Õ¥Î¤F¨ìºÞ¥]§tmAb ©M20 m l 1:1 ³J¥Õ½èA sepharose ªd¼ß, ¨Ã¥BºÞ¹j©]¬O³QÂà°Êªºµ²§ô¦bµ²§ô¦b4 oC ¡C

5. immunoprecipitate µM«á³Q¬~º°¤F¦Ü¤Ö6 ¦¸»PMES ÆQbuffer(20 ¾÷¾¹»y¨¥MES »ÄÆP«×6.8, 20 ²@¦ÌNaCl, 1 ²@¦ÌEDTA) 5 min. ¦U­Ó¡C

6. ¤p¯]³Q®gÀ»¤F2 min. ¦bmicrofuge, ­«·sÄa±¾¤J2 x SDS ½d¨Ò½w½Ä, µNªm5 min. ¦b90 oC ¨F¤l¯D¡C

7. ªd¼ß¦A³Q®gÀ»¤F, «O¯d©M¤W¼h²M²G¡C

8. ¹B¦æSDS-PAGE ¡C

(P.C., 01/30/95)

ª`:

IgG ­«ªºÃì¤l±N¹B¦æ¦b50kd

IgG »´ªºÃì¤l±N¹B¦æ¦b22kd

¾ãÅéIgG ¹B¦æ¦b150kd

»Ý­n¾á¤ß¬~º°¾¯³Q¨Ï¥Î·»¸Ñ¹q¦À¸T¤îAb ®¹¸j¡C

»Ý­n¾á¤ßimmunocomplex ¬O¥i·»¸Ñ¡C

»Ý­n¤u§@¦b¬Ûµ¥(Ag:Ab ¤ñ²v) °Ï°ì¡C

¥N´À2� GAMIgG ¥i¯à¨Ï¥Î¾ãÅ鸲µå²yµßaureus, ³J¥Õ½èA, §ó¦n¤ñ³J¥Õ½èA, Prot.A/Prot.G ²V¦Xªº³J¥Õ½èG (¥Öº¸´µ¡PImmunochemicals), ©Îantimouse §ô¿£¹ïIgG1 Affigel ¡C

¯à±qimmunocomplex µo¦æ§Ü­ì®Ú¾Ú0.1M ®ò°ò¤A»Ä»ÄÆP«×2.5 »Ä¾_°Ê, ©Î°ªÆQ(3M NaSCN) ¾_°Ê, µM«á³q¹L³q¹LCostar Spinex 0.22m m ¸É¥Õ³¡¥ó¤JEppendorf ¡C

¯à¼W¥[1� ºw©w¶q; mAb ¥Ñ³q¹L9E10 ´CÅéSepharose CNBr ¤p¯], ³o§ô¿£IgG ªº5 ­Ó©Î§ó¦hFc ³¡¥÷¦³®Ä°µ¥¦IgM ¡C

¯à¼W¥[1� ºw©w¶q; mAb ¥Ñ²K¥[¹¡©MªºNH4SO4 ªº¬Ûµ¥ªº¼Æ¶qdropwise ¨ÓÂà°Ê9E10 ´CÅé¦broomtemp, ®gÀ»¨I¾ýª«¦b2500g ¬°5min, ­«·sÄa±¾®ç¬õ¦â(RPMI) ÃĤY¦bdH20, ­«½Æ­°«B³·¡C

°µ¹¡©MªºNH4SO4: µNªm¤ô, ²K¥[NH4SO4 ª½¨ì¤ô´¹¸¨¦b¸Ñ¨M¤èªk¥~­±, §NÀR¨ÓRT, »ÄÆP«×¨ì7.0 »PNH4Cl, ¹LÂo³q¹L3MM ¯È¡C

¯à¥Íªø9E10 ¹q¦À¦b2% FCS ­°§Cªg¬VIg ¡C

·L¤pµ¥¯Å§ÜÅ饿´«¿Ë¦X¤O¬~²b¬°¾½µßªº§J¶©ªº¶¡±µ¿Ã¥ú§K¬ÌÀËÅçªk©Mepitope ¿ï¾Ü¡C

³o­Ó¨óij§Q¥Î±¡ªp§ÜÅ騳³t¦a½Õ¥Î¦b§Ü­ì½d¨Ò¤§¶¡ªþ¤W¤ÀÂ÷°í¹ê§Þ³N¤ä«ù¡C¥¦¤ñ§Ü­ìpicamole ¤¹³\¤@¹ï¿Ë¦X¤O²b¤Æ¤Ö¶q§ÜÅé¨Ï¥Î¸û¤Ö¡C³o¬O°¶¤jªº¬°°µ¿Ã¥ú§K¬ÌÀËÅçªk»Pµu¯Ê©Î§Ü­ìµu¯Êªº»êżªº§ÜÅé, ©Î¬°§Ö³t¿z¿ïªí¹F¦¡§J¶©¬°epitope ¿ï¾Ü¡C

¬°¿Ã¥ú§K¬ÌÀËÅçªk:

1. ©T©w±zªº§Ü­ì¦b¤@1 cm2 µv¤ÆÅÖºû¯Àªä¤ù¡C¨Ò¦p, ¹îı¦¾ÂI1-10 ng ·í¦aDicty dynein ¦b10 m l P100 ½w½Äµv¤ÆÅÖºû¯Àªä¤ù¡C³o¬O±zªº¨Ó·½¦¾ÂI¡C°µ¤@­Ó¨Ó·½¦¾ÂI¬°±z§Æ±æ§Ëżªº¨Ccoverslip ¡C

2. Åýµv¤ÆÅÖºû¯À°®Àê¼Ð°O³J¥Õ½è¤ä«ù»P¹]µ§¡C¶ô¦b5% milk/PBS 30 ¤ÀÄÁ¡C¨Ó·½¦¾ÂI¥i¯à³Q¦sÀx¦bªýÄd¸Ñ¨M¤èªk¦b¦B½c¦pªGNaN3 ³Q²K¥[¨Ó0.02% ¡C

3. ¹å¤Æ§Ü­ì¨Ó·½¦¾ÂI»P§ÜÅé¦bPBS/0.1%BSA 4 ®É¼Æ¹ï¹j©]¡C³B²z¦¾ÂI»Pª½¨¥ªºÆh¤l¡C¨Ï¥Îµ¹¦nµ²ªG¥H¦è³¡¦¾ÂI§ÜÅ骺µ}ÄÀ¡C¤«¦b24-well ªO§÷¬O¦nªº¬°³o¦pªG±z¦³´X­Ó½d¨Ò¡C

4. ¬~º°¨Ó·½§Ëż3 ­¼5 ¤ÀÄÁ»PPBS/0.5% «DÂ÷¤l¬¡©Ê¾¯20 ¡C

5. coverslip ½d¨Ò¬°¶¡±µ¿Ã¥ú§K¬ÌÀËÅçªk°µ·Ç³Æ(°Ñ¨£¬ÛÃöªº³¡¤À¦blabman) ¡C¦w¸m50 m l PBS ¦b©T©w, «ÊÂꪺcoverslip ¡C¦w¸m³Q¬~º°ªº¨Ó·½¦¾ÂI, antigen/Ab ½ÆÂø¤U¨Ó, ¦bcoverslip ³»³¡¡C¹å¤Æ¦b37 «×, 1 ®É¼Æ, ¦b¼éÀã¤À®x¡C§ÜÅé¦b¨Ó·½¦¾ÂI¨³³t¦a±N¥­§¡»P§Ü­ì¦b©T©wªº¹q¦À¦bcoverslip ¡CÄ~Äò¶i¦æ¬~º°©MªþÄݧÜÅ饿¦p¨C¿Ã¥ú§K¬ÌÀËÅçªk¨óij¡C

6. ¨Ó·½¦¾ÂI¥i¯à³Q­«·s¨Ï¥Î¦pªG¼sªx¦a¬~º°©M¦sÀx¦bPBS/0.1% BSA/0.02% NaN3 ¡C¨C¦¸Re-incubate »P§ÜÅé¡C

¬°ªí¹F¦¡§J¶©ªºepitope ¿ï¾Ü

1. ªø¤j±K¶°IPTG ¾É­P(clonal!) ¾½µßªºªO§÷©M±À¤Oªí¹F¤F¿Ä¦X³J¥Õ½èµv¤ÆÅÖºû¯À¸É¥Õ©M¥­±`¤@¼Ë¡C

2. ªýÄd¾½µßªº¸É¥Õ¦b5% milk/PBS 30 ¤ÀÄÁ¡C¹å¤Æ»P§ÜÅé1-4 ®É¼Æ¦b¦P¼Ëµ}ÄÀ¨Ï¥Î¿z¿ï¾½µßªº¹Ï®ÑÀ]¡C¬~º°¸É¥Õ¦bPBS ¡C³o¨Ç¬O±zªº¨Ó·½¸É¥Õ¡C

3. ¹B¦æ³Q²b¤Æªº©Î³QÂ×´Iªº§Ü­ì½d¨Òªºµ¡©©SDS ½¦¾®Åé¡C§Ëż½¦¾®Åéµv¤ÆÅÖºû¯À©M¼Ð°O³J¥Õ½èÃä¥H¤@±ø¹]µ§½u¸ô¾î¸ó¦¾ÂIªº¾ã­Ó¼e«×¡C¶ô¦b5% milk/PBS ¬°30 ¤ÀÄÁ©M°Å¤Á¦¨¤p±ø¡C

4. ¹å¤Æ¦U¨Ó·½¸É¥Õ³Q´ú¸Õ¥Hµ¡©©½¦¾®Åé¤p±ø¡C¦w¸m¨Ó·½¸É¥Õ©M¦¾ÂI¤p±ø¥H³J¥Õ½èÃä­±¹ï¦b±K«Ê¿¯­¹³U¤l¡C²K¥[­è°÷PBS/0.1%BSA §ËÀã¨â­Ó¦¾ÂI¡C±K«Ê³U¤l¡C³o®É¤£­n²K¥[§ÜÅé!

5. ¤@°_¹å¤Æ¦¾ÂI1-4 ®É¼Æ¡CµM«á¼sªx¦a¨ú®ø¦¾ÂI¤p±ø©M¬~º°¦bPBS ¡C¤£­n²V¦X¤p±ø¦b¬~º°ªº¸Ñ¨M¤èªk©ÎªþÄݧÜÅé¸Ñ¨M¤èªk, ¦p¦P§ÜÅé¤]³\½Õ¥Î¦b¤p±ø¤§¶¡¡C¹å¤Æ¤p±ø¦b¾A·íªºªþÄݧÜÅé1 ­Ó¤p®É¡C¬~º°©M¶}µo¤p±ø¡C

6. ¦pªG¾½µßªº§J¶©¿é¤J¤@¯u¹ê¦a¥¿DNA, ¹ïÀ³ªº¤p±ø±N¬O¥¿¡C­t¤p±øªí©ú°²ªº¥¿¾½µßªº§J¶©¡C

1/95, Trivinos

(±qHammarback ©MVallee 1990 ¦~, JBC 265:12763)

¬°®É¥ÑCellbiogal ½s¿è; 09-06-2006 ¤U¤È08:09¡C
Digg ³oµ§¹L±b!²K¥[¹L±b¨Ódel.icio.us«ö®Ññ¹L±b¦bTechnoratiFurl ³oµ§¹L±b!Spurl ³oµ§¹L±b!Reddit!
¦^´_¥H³ø»ù
Alt ¤µ¤Ñ
°µ¼s§i
Google Adsense
 
³o°µ¼s§i¤£·&³QÅã¥Ü
³o¼Ë¹ïµn°Oªº¦¨­û¡C
¤µ¤Ñ µn°O±zªº¦Û¥Ñ±b¤á
¨Ã¥B¦¨¬°¦¨­û
¤À¤l¥Íª«¾Ç½×¾Â
¼Ð·Ç ³QÃÙ§Uªº³sµ²

  #2 (permalink)  
¦Ñ 02-17-2008, ¤U¤È02:00
§l²¾ºÞ¸É¥Õ
ÂI:131, ¯Å§O:2ÂI:131, ¯Å§O:2ÂI:131, ¯Å§O:2
¬¡°Ê:0%¬¡°Ê:0%¬¡°Ê:0%
 

³s±µ¤é´Á: 2008 ¦~¤G¤ë
¦aÂI: Maadi
¹L±b: 4
remo RSS µ²Âà
Àq»{­È Re: Monoclonal §ÜÅ骺¥Í²£- §Þ³N¦b·Æ¹«

°ª
Iwant ª¾¹DÃö©ógenomic §ÜÅé§Þ³N
Digg ³oµ§¹L±b!²K¥[¹L±b¨Ódel.icio.us«ö®Ññ¹L±b¦bTechnoratiFurl ³oµ§¹L±b!Spurl ³oµ§¹L±b!Reddit!
¦^´_¥H³ø»ù
¦^´_

½uµ{¼Æ¤u¨ã
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Denaturation of Mouse Antibodies? deebee12 Antibody Forum 0 04-15-2008 10:53 AM
Production of Monoclonal Antibodies Cellbiogal Antibody Forum 5 02-17-2008 01:57 PM
Monoclonal Antibodies for Immunoprecipitation dave2006 Antibody Forum 0 01-22-2008 11:03 AM


All times are GMT. The time now is 12:38 PM.


Powered by vBulletin® Version 3.7.1
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Copyright 2005-2007 Molecular Station & All Rights Reserved
WARNING: SYSTRANLinks did not translate the document entirely. The document exceeds the maximum size allowed by the solution. ( 65536 bytes for HTML)